Methylxanthine therapy for apnea of prematurity: Evaluation of treatment benefits and risks at age 5 years in the International Caffeine for Apnea of Prematurity (CAP) Trial Other Refereed Contribution to Refereed Journals uri icon

Overview

Published in

  • Biology of the Neonate

Time

Date/time value

  • 2005

Additional Document Info

Parent Title

  • Biology of the Neonate

Volume

  • 88

Issue

  • 10

Publisher

  • S Karger AG